UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

HealthBridge Pharma & Biotech - June 21, 2012
Specialty patients often face complex and costly treatments for their therapies. Nonadherence among these patients can lead to expensive and dangerous adverse health effects.  Research shows that keeping one organ transplant...
, Director, Business Development - June 15, 2012
During 2012, patents for six drugs will expire, accounting for more than $30 billion in drug spend.  So, the discussions I had with colleagues at this week’s EyeforPharma Sales Force Effectiveness & Commercial Excellence...
, Director, Business Development - June 13, 2012
Few other fields change as rapidly as the healthcare field.  And, for me, that’s a good thing.  I enjoy the constant challenge of finding innovative ways to help pharmaceutical manufacturers provide life-changing drugs to...
HealthBridge Pharma & Biotech - June 06, 2012
Since the founding of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in 1995, United BioSource has been active in the ISPOR organization and continues to find its annual meeting vital for educational...
Aimee Tharaldson, senior clinical consultant, Emerging Therapeutics, Express Scripts - June 04, 2012
Over the last two weeks, the Senate and the House passed their versions of the Food and Drug Administration Safety and Innovation Act. Conference committees will now work together to come up with a compromise, which could potentially...

Pages